Literature DB >> 24147563

Inhaled corticosteroids for asthma: on-demand or continuous use.

Neil C Thomson1, Mark Spears.   

Abstract

Continuous inhaled corticosteroid treatment is highly effective in children and adults with mild persistent asthma, although some therapeutic benefits are not lost if treatment is delayed. Many patients do not adhere to continuous treatment with inhaled corticosteroids, but rather take them intermittently, usually at the time of increased symptoms. Based on these observations it has been proposed that for patients with mild persistent asthma inhaled corticosteroids should be used on-demand when symptoms are troublesome, rather than on a continuous basis. The article reviews the pharmacological properties of inhaled corticosteroids used in clinical trials of on-demand treatment, as well as the evidence for the efficacy and safety of on-demand compared with continuous inhaled corticosteroid treatment of mild persistent asthma in adults and children. The place of on-demand treatment with inhaled corticosteroids in the management of asthma is discussed, as well as future directions for different management strategies for this group.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24147563     DOI: 10.1586/17476348.2013.836062

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  3 in total

Review 1.  Inhaled corticosteroids and risk of influenza in patients with asthma: a meta-analysis of randomized controlled trials.

Authors:  Hong Chen; Zhibo Xu; Jing Yang; Lan Huang; Ke Wang
Journal:  Aging Clin Exp Res       Date:  2020-10-07       Impact factor: 3.636

2.  Establishment of different experimental asthma models in mice.

Authors:  Qian-Lin Yu; Zhangbo Chen
Journal:  Exp Ther Med       Date:  2018-01-08       Impact factor: 2.447

3.  Comparing the Protection Imparted by Different Fraction Extracts of Garlic (Allium sativum L.) against Der p-Induced Allergic Airway Inflammation in Mice.

Authors:  Chia-Chen Hsieh; Keng-Fan Liu; Pei-Chun Liu; Yaw-Tsan Ho; Wei-Sung Li; Wen-Huang Peng; Jen-Chieh Tsai
Journal:  Int J Mol Sci       Date:  2019-10-01       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.